Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
DLA from Anderlecht, company number BE0639768151, closed financial year 2025 with a result of € 57,210 after tax. For that financial year DLA recorded a gross margin of € 49,557 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 63,097 to € 57,210. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 1.1 million
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 57,210
▼ 9% vs 2024
Profit after tax over the fiscal year.
€ 46,134
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 199,878.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 24,682
▼ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,221
▲ 103% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 45,787 | € 46,797 | € 47,873 | € 49,557 | ▲ 4% |
| Profit after taxes | € 45,315 | € 57,962 | € 63,097 | € 57,210 | ▼ 9% |
| Equity | € 889,609 | € 947,571 | € 1,010,668 | € 1,067,878 | ▲ 6% |
| Total debts | € 29,740 | € 38,310 | € 37,769 | € 30,903 | ▼ 18% |
| Cash | € 32,511 | € 61,726 | € 54,291 | € 46,134 | ▼ 15% |
| Retained profit | € 21,609 | € 79,571 | € 142,668 | € 199,878 | ▲ 40% |
| Balance sheet total | € 919,349 | € 985,881 | € 1,048,437 | € 1,098,781 | ▲ 5% |
Key figures of DLA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DLA?
What happened at DLA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 57,210 (▼ 9% vs 2024). Source: NBB ↗
- Geert Reyniers became a director. NBB
- New establishment in Schaarbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 45,315 profit in 2022 to € 57,210 profit in 2025.
Paid € 68,547 in corporate taxes since 2022.
Best year ever: 2024, with € 63,097 profit.
A new publication or filing at DLA? We notify you, reason included.
Follow DLADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Goed Farma, Popelin Apotheken comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DLABehind DLA is Geert Reyniers. The shares are held by Goed Farma (100%) and Popelin Apotheken (99.9%).
Directors
According to the 2025 annual accounts
Geert Reyniers
Director
Also active at: MULTIPHARMA GROUP, APOTHEEK SMISHOEK, Apotheek Willebroek, Apoteek Jespers - Cuijpers, APOTHEEK BOGAERT, APOTEEK P. Sergeant, APOTHEEK VANDYCK, PHARMACIE LAURENT DELCOURT +12 more
since 2025
Shareholders
100%
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Marie Curiesquare 30
1070 Anderlecht
Haachtsesteenweg 579
1030 Schaarbeek
Active since 1 October 2015
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →MULTIPHARMA GROUP same network
Office des sociétés coopératives de grossistes pharmaceutiques et de pharmacies - Vereniging van coöperatieve vennootschappen van farmaceutische groothandelaars en apotheken
Apoteek Jespers - Cuijpers same network
€ 113,239 gross margin · 2025
APOTEEK P. Sergeant same network
€ 10,336 gross margin · 2025
APOTHEEK VANDYCK same network
€ 1,703 gross margin · 2025
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0639.768.151
- VAT number
- BE 0639.768.151
- Registered office
- Marie Curiesquare 30, 1070 Anderlecht
- Names & denominations
- DLA
- Enterprise type
- Rechtspersoon
- Legal form
- General partnership
- Legal situation
- Normale toestand
- Start date
- 1 October 2015
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- 32 3 206 82 10
- Activities · NACE
Overige zakelijke dienstverlening, neg